# Immunogenicity and Safety of V70P5 Revaccination Subjects

> **NCT01210898** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 197 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Adjuvanted seasonal influenza vaccine

## Key facts

- **NCT ID:** NCT01210898
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-01
- **Final completion:** 2011-12
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2016-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210898, "Immunogenicity and Safety of V70P5 Revaccination Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01210898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*